Chlamydia trachomatis infections - A time for action?;Chlamydia-trachomatis-infektionen - Zeit zum handeln?

Deutsche Medizinische Wochenschrift

Volumn 132, Issue 21, 2007, Pages 1170-1176

  Mylonas, Ioannis ^a   Kirschner, W ^b   Weissenbacher, T ^a   Gingelmaier, A ^a   Weissenbacher, E R ^a   Friese, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Forschungs Instituts   (Germany)

Author keywords

Chlamydia trachomatis; Diagnosis; Prevalnece; Screening; Treatment

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; LEVOFLOXACIN; OFLOXACIN;

ANTIBIOTIC THERAPY; CELL CULTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DNA PROBE; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE AMPLIFICATION; HUMAN; INFERTILITY; PELVIC INFLAMMATORY DISEASE; POINT OF CARE TESTING; PREVALENCE; REVIEW; RISK FACTOR; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE;

ADULT; AGE FACTORS; ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; POLYMERASE CHAIN REACTION; PREVALENCE; PUBLIC HEALTH; SEXUALLY TRANSMITTED DISEASES, BACTERIAL;

EID: 34447340277     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979394     Document Type: Review

References (50)

1. Boyer CB, Shafer MA et al. Sexually transmitted diseases in a health maintenance organization teen clinic: associations of race, partner's age, and marijuana use. Arch Pediatr Adolesc Med 1999; 153: 838-844
2. Jr. Cates W. Chlamydial infections and the risk of ectopic pregnancy. Jama 1999; 281: 117-118
3. Jr. Cates W, Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991; 164: 1771-1781
4. Chokephaibulkit K, Patamasucon P, List M, Moore B, Rodriguez H. Genital Chlamydia trachomatis infection in pregnant adolescents in east Tennessee. J Pediatr Adolesc Gynecol 1997; 10: 95-100
5. Clad A, Prillwitz J, Hintz KC et al. Discordant prevalence of chlamydia trachomatis in asymptomatic couples screened using urine ligase chain reaction. Eur J Clin Microbiol Infect Dis 2001; 20: 324-328
6. Cohen DA, Nsuami M, Martin DH, Farley TA. Repeated school-based screening for sexually transmitted diseases: a feasible strategy for reaching adolescents. Pediatrics 1999; 104: 1281-1285
7. Cohen I, Veille JC, Calkins BM. Improved pregnancy outcome following successful treatment of chlamydial infection. Jama 1990; 263: 3160-3163
8. Currie MJ, McNiven M, Yee T, Schiemer U, Bowden FJ. Pooling of clinical specimens prior to testing for Chlamydia trachomatis by PCR is accurate and cost saving. J Clin Microbiol 2004; 42: 4866-4867
9. Eggert-Kruse W, Rohr G. Kunt B et al. Prevalence of Chlamydia trachomatis in subfertile couples. Fertil Steril 2003; 80: 660-663
10. Friese K, Schäfer A, Hof H. Infektionen in der Gynäkologie und Geburtshilfe. Berlin Heidelberg New York Tokio, Springer, 2002
11. Friese K, Schröder G, Beichert M, Melchert F. Determination of the prevalence of Chlamydia trachomatis in women in the area of Mannheim, Germany, by using the Abbott Testpack Chlamydia rapid enzyme immunoassay. Klinisches Labor 1994; 40: 637-640
12. Gaydos CA, Howell MR, Pare B et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998; 339: 739-744
13. Genc M, Mardh A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996; 124: 1-7
14. Gilles G, Klapp C, Diedrich K, Schaefer A. Chlamydien - eine heimliche Epidemie unter Jugendlichen. Dtsch Arztebl 2005; 102: A2021-A2025
15. Ginocchio RH, Veenstra DL, Connell FA, Marrazzo JM. The clinical and economic consequences of screening young men for genital chlamydial infection. Sex Transm Dis 2003; 30: 99-106
16. Goeree R, Jang D, Blockhouse G et al. Cost-effectiveness of screening swab or urine specimens for Chlamydia trachomatis from young Canadian women in Ontario. Sex Transm Dis 2001; 28: 701-709
17. Honey E, Augood C, Templeton A et al. Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect 2002; 78: 406-412
18. Honey E, Templeton A. Prevention of pelvic inflammatory disease by the control of C. trachomatis infection. Int J Gynaecol Obstet 2002; 78: 257-261
19. Howell MR, Gaydos JC, Jr. McKee KT, Quinn TC, Gaydos CA. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. Sex Transm Dis 1999; 26: 519-526
20. Howell MR, Quinn TC, Brathwaite W, Gaydos CA. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transm Dis 1998; 25: 108-117
21. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med 1998; 128: 277-284
22. Hu D, 3rd Hook EW, Goldie SJ. Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis. Ann Intern Med 2004; 141: 501-513
23. Kent CK, Branzuela A, Fischer L, Bascom T, Klausner JD. Chlamydia and gonorrhea screening in San Francisco high schools. Sex Transm Dis 2002; 29: 373-375
24. Koch J, Kirschner W, Schäfer A. Bestimmung der Praevalenz genitaler HPV-und Chlamydia-trachomatis-Infektionen in einem repraesentativen Querschnitt der weiblichen Normalbevoelkerung in Berlin. Infektionsepidemiologische Forschung, 1997
25. La Montagne DS, Patrick LE, Fine DN, Marrazzo JM. Re-evaluating selective screening criteria for Chlamydial infection among women in the U S Pacific Northwest. Sex Transm Dis 2004; 31: 283-289
26. Mangione-Smith R, O'Leary J, McGlynn EA. Health and cost-benefits of chlamydia screening in young women. Sex Transm Dis 1999; 26: 309-316
27. Marrazzo JM, Celum CL, Hillis SD et al. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis 1997; 24: 131-141
28. Marrazzo JM, Fine D, Celum CL, DeLisle S, Handsfield HH. Selective screening for chlamydial infection in women: a comparison of three sets of criteria. Fam Plann Perspect 1997; 29: 158-162
29. Martius J, Krohn MA, Hillier SL et al. Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol 1988; 71: 89-95
30. McGregor JA, French JI. Chlamydia trachomatis infection during pregnancy. Am J Obstet Gynecol 1991; 164: 1782-1789
31. Miller WC, Ford CA, Morris M et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. Jama 2004; 291: 2229-2236
32. Miller WC, Hoffman IF, O'Owen-Dowd J et al. Selective screening for chlamydial infection: which criteria to use? Am J Prev Med 2000; 18: 115-122
33. Nelson HD, Helfand M. Screening for chlamydial infection. Am J Prev Med 2001; 20: 95-107
34. Nsuami M, Elie M, Brooks BN et al. Screening for sexually transmitted diseases during preparticipation sports examination of high school adolescents. J Adolesc Health 2003; 32: 336-339
35. Nyari T, Deak J, Nagy E et al. Epidemiological study of Chlamydia trachomatis infection in pregnant women in Hungary. Sex Transm Infect 1998; 74: 213-215
36. Nyari T, Nyari C, Woodward M et al. Screening for Chlamydia trachomatis in asymptomatic women in Hungary. An epidemiological and cost-effectiveness analysis. Acta Obstet Gynecol Scand 2001; 80: 300-306
37. Oakeshott P, Kerry S, Hay S, Hay P. Opportunistic screening for chlamydial infection at time of cervical smear testing in general practice: prevalence study. Bmj 1998; 316: 351-352
38. Oh MK, Richey CM, Pate MS, Brown PR, 3rd Hook EW. High prevalence of Chlamydia trachomatis infections in adolescent females not having pelvic examinations: utility of PCR-based urine screening in urban adolescent clinic setting. J Adolesc Health 1997; 21: 80-86
39. Paavonen J, Puolakkainen M, Paukku M, Sintonen H. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol 1998; 92: 292-298
40. Rietmeijer CA, Bull SS, Ortiz CG, Leroux T Jr. Douglas JM. Patterns of general health care and STD services use among high-risk youth in Denver participating in community-based urine chlamydia screening. Sex Transm Dis 1998; 25: 457-463
41. Rimbach S, Wallwiener D, Baier S et al. Chlamydia trachomatis: screening within the scope of prenatal care and rapid diagnosis in threatened premature labor. Zentralbl Gynakol 1993; 115: 478-482
42. Robert Koch-Institut. Gonorrhö und genitale Chlamydiose in Deutschland nach Daten des STD-Sentinels des RKI. Epidemiologisches Bulletin, 2004: 39
43. Jr. Ryan GM, Abdella TN, McNeeley SG, Baselski VS, Drummond DE. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am J Obstet Gynecol 1990; 162: 34-39
44. Schachter J, Grossman M, Sweet RL et al. Prospective study of perinatal transmission of Chlamydia trachomatis. Jama 1986; 255: 3374-3377
45. Stamm WE, Hicks CB, Martin DH et al. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. Jama 1995; 274: 545-549
46. Stergachis A, Scholes D, Heidrich FE et al. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol 1993; 138: 143-153
47. Stock C, Guillen-Grima F, Prufer-Kramer L et al. Sexual behavior and the prevalence of Chlamydia trachomatis infection in asymptomatic students in Germany and Spain. Eur J Epidemiol 2001; 17: 385-390
48. van Valkengoed IG, Postma MJ, Morre SA et al. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens. Sex Transm Infect 2001; 77: 276-282
49. Welte R, Kretzschmar M, Leidl R et al. Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. Sex Transm Dis 2000; 27: 518-529
50. Westrom L, Wolner-Hanssen P. Pathogenesis of pelvic inflammatory disease. Genitourin Med 1993; 69: 9-17